export const data = {
    body: [
        { component: "title", text: "Complications and Emergencies" },

        { component: "line" },
        { component: "heading", text: "Malignant Hyperthermia" },
        { component: "para", bold: "Definition: ", text: "A rare autosomal dominant genetic condition that can be triggered by certain anesthetic agents leading to ↑↑ Ca2+ release, sustained muscle contraction, and hyper- metabolic crisis." },
        { component: "para", bold: "Triggers: ", text: "Succinylcholine, volatile agents (except N2O)."},
        { component: "para", bold: "Signs/Symptoms: ", text: "Early: ↑ ETCO2, ↓ SpO2, ↑ HR, ↑ RR, masseter spasm", component:"line", text: "Late: HTN, total body rigidity, severe lactic acidosis, hyperthermia, rhabdomyolysis." },
        { component: "para", bold: "Complications: ", text: "Hyperthermia, hyperK+, arrhythmias, DIC, AKI, cerebral edema, compart- ment syndrome, cardiac arrest, death."},
        { component: "para", bold: "DDx: ", text: "Light anesthesia, insufflation with CO2, thyroid storm, sepsis, pheochromocytoma, serotonin-syndrome, neuroleptic malignant syndrome."},
        { component: "para", bold: "Risk factors: ", text: "F/Hx of MH, unexplained fever/cramps/weakness, myopathies."},
        { component: "para", bold: "Prevention: ", text: "Identify at-risk patients through F/Hx, book as first case of the day, replace circuit/CO2 absorbers, remove vaporizers and flush machine, remove succinylcholine vials from cart, TIVA, carefully monitor ETCO2 and temperature, have dantrolene available."},
        { component: "para", bold: "Management: ", text: "Stop succinylcholine/volatile agents, 100% FiO2, push dantrolene, treat K+ abnormalities and acidosis, increase minute ventilation, cool patient, supportive care; consider muscle biopsy/genetic testing post-op."},
        
        { component: "line" },
        { component: "heading", text: "Pseudocholinesterase Deficiency" },
        { component: "para", bold: "Definition: ", text: "An autosomal recessive genetic condition in which there is a deficiency in the enzyme that breaks down certain anesthetic drugs."},
        { component: "para", bold: "Triggers: ", text: "Succinylcholine, mivacurium."},
        { component: "para", bold: "Signs/Symptoms: ", text: "Prolonged respiratory paralysis/apnea."},
        { component: "para", bold: "Complications: ", text: "Prolonged mechanical ventilation, respiratory failure if extubated early."},
        { component: "para", bold: "DDx: ", text: "Diaphragmatic paralysis, hypoK+, hyperMg2+."},
        { component: "para", bold: "Risk factors: ", text: "Use of succinylcholine, F/Hx of pseudocholinesterase deficiency or unex- plained extended paralysis under general anesthesia."},
        { component: "para", bold: "Prevention: ", text: "Identify at-risk patient and avoid triggering agents."},
        { component: "para", bold: "Management: ", text: "Continue mechanical ventilation and hemodynamic support until paralysis self-resolves; record condition in patient chart."},

        { component: "quiz", question: "", options: [""], answer: "" },
    ]
};